AUS
NZ
UK
CA
USA
IND
Summary
- Australian Natural Therapeutics Group enters a partnership with NUBU Pharmaceuticals to ship medicinal cannabis flower to New Zealand.
- The agreement would boost the Trans-Tasman relationship.
- ANTG's products confirm the global norms of GMP and GACP.
With COVID-19 showing no signs of retreat, the novel coronavirus is wreaking havoc around the world with millions of people getting contracted with the virus and death tolls surmounting every day.
Early studies have suggested that medicinal cannabis might have the capability to treat the symptoms of the deadly virus and minimise the gravity of it.
Must Read: How to invest in the booming cannabis sector?
Cannabinoids such as cannabidiol (CBD) with their anti-inflammatory properties have therapeutic benefits in lessening pain and anxiety and have the potential to cure the symptoms of COVID-19.
Many pharmaceutical and healthcare companies are continuously researching on it to find a valid cure for the virus and achieve a breakthrough, which provides relief to the entire humanity.
Source: Copyright © 2021 Kalkine Media Pty Ltd
Historic Medicinal Cannabis Partnership Between Aussies And Kiwis
Australian Natural Therapeutics Group, which deals in medicinal cannabis, announced on 4 May 2021 the collaboration with NUBU Pharmaceuticals, New Zealand’s biggest medicinal cannabis distributor.
Do Not Miss Reading: Medicinal cannabis industry in NZ is set to boom despite hurdles
For the first time in the history of Australia, locally grown medicinal cannabis flowers will be transported to New Zealand in the second half of 2021.
It must be noted that ANTG entered into a partnership with Germany’s Cannamedical Pharma and had exported the first batch of home-grown medicinal cannabis to Germany in January 2021. The agreement is likely to be around worth $92 million over the next 10 years.
About ANTG
Established in 2015, ANTG produces high-quality cannabinoids for use in medical treatments. It lays emphasis on strong R&D methods to produce and develop cannabinoid medicines, which provide therapeutic cures to the patients.
About NUBU Pharmaceuticals
Formed in 2017, this NZ-based company, is one of leading medicinal cannabis firms in the country. It aims at distributing beneficial cannabis products in the NZ market and exports home-grown cannabis products in the global markets.
Mutual Benefits For Both The Countries
Matthew Cantelo, ANTG’s CEO, opined that the strategic pact between the companies of both the countries would further strengthen the Trans-Tasman relationship. He also stated that that was a significant deal in the history of both the neighbours, where ANTG would be the first Aussie company to ship its domestically grown cannabis flower into the Kiwiland.
Compliance With International Standards
Cantelo further expressed that ANTG products would first cater to the Australian patients and are grown to meet Good Manufacturing Practices (GMP) and Good Agricultural and Collection Practices standards.
Moreover, its products also comply with the norms of Therapeutic Goods Standards for Medicinal Cannabis (TG093 & TG0100), thereby ascertaining that they are free from harmful adulterants like moulds, microbials, and yeast.
